Abstract:Cow milk allergy is a common phenomenon experienced in early childhood (<5 yr of age) with an average occurrence rate of roughly 2.5%. The most prevalent allergen in cow milk is believed to be β-LG. The objective of this study was to evaluate the use of hydrophobic supercritical CO2 (ScCO2) to modify the chemical structure β-LG, thus impairing its recognition by antibodies. Whole milk powder (WMP) was selected because of its closest compositional resemblance to bovine fluid milk and its applications in reconstitution and in the beverage (infant, toddler, and adult), confectionary, bakery, and meat industries. For this study, WMP was treated with food-grade CO2 at temperatures of 50, 63, and 75°C under operating pressures of 100, 150, 200, 250, and 300 bar. Proteins in WMP were examined using SDS-PAGE, western blot, and ELISA. Orbitrap Fusion liquid chromatography-tandem MS (LC-MS/MS) and periodic staining was performed to confirm post-translational modifications in β-LG. Functional properties of WMP before and after treatment were assessed by its solubility index, oil holding capacity, emulsion capacity and stability, zeta potential, particle size, and color analysis. SDS-PAGE of treated samples yielded fuzzy bands (variable mobility of molecules due to different molecular weights results in ill-defined bands) indicative of an increase in molecular weight, presumably due to chemical change in the protein, and demonstrated a maximum of 71.13 ± 0.29% decrease in the band intensity of β-LG under treatment conditions of 75°C/300 bar for 30 min. These changes were small with samples treated with heat only. Lighter, diffused bands were observed using western blot analysis. The ELISA tests proved that ScCO2 treatment specifically and significantly affected the antigenicity of β-LG with a reduction of 42.9 ± 2.83% and 54.75 ± 2.43% at 63°C/200 bar and 75°C/300 bar, respectively. Orbitrap fusion detected the presence of fatty acids and sugar moieties bound to β-LG and the latter was confirmed by periodic staining. Functional properties of ScCO2-treated milk powder yielded a decrease in solubility index and an increase in emulsion capacity of WMP was observed under ScCO2 treatment at 75°C/300 bar, with small and insignificant changes at other treatments producing a decrease in antigenicity. Color changes were small for most samples, except at 63°C/200 bar, where a significant increase in yellowness was observed. Zeta potential and particle size measurements indicated that most changes were temperature driven. This study demonstrates 2 approaches to mitigate β-LG antigenicity via fatty acid binding and lactosylation using hydrophobic ScCO2.

Experimental and Computational Studies on the Mechanism of the Β-Lactoglobulin-derived Peptide Inhibiting the Antigenicity of Β-Lactoglobulin

Reduction in the antigenicity of beta-lactoglobulin in whole milk powder via supercritical CO2 treatment

Reducing Antigenicity and Improving Antioxidant Capacity of Β-Lactoglobulin Through Covalent Interaction with Six Flavonoids.

The Mechanism of Epigallocatechin-3-gallate Inhibiting the Antigenicity of Β-Lactoglobulin under Ph 6.2, 7.4 and 8.2: Multi-spectroscopy and Molecular Simulation Methods

Modulating Whey Proteins Antigenicity with Lactobacillus delbrueckii subsp. bulgaricus DLPU F-36 Metabolites: Insights from Spectroscopic and Molecular Docking Studies

Screening of specific binding peptide for β-lactoglobulin using phage display technology

Six Flavonoids Inhibit the Antigenicity of Β-Lactoglobulin by Noncovalent Interactions: A Spectroscopic and Molecular Docking Study.

Allergenicity Reduction of Bovine Β-Lactoglobulin Binding to Lactic Acid by Masking Epitopes with Lactylation

Studies on Amino Acid Replacement and Inhibitory Activity of a Β-Lactamase Inhibitory Peptide

Study on the Antigenicity of Whey Proteins during Fermentation with Lactobacillus helveticus

Comparison of Sensitization Between Beta-Lactoglobulin and Its Hydrolysates.

Zwitterionic Peptide Pendant As a Homing Agent to Achieve Lymphatic Targeting Antigen-Specific Immunotherapy of Allergenic Protein

Covalent or non-covalent binding of polyphenols, polysaccharides, metal ions and nanoparticles to beta-lactoglobulin and advanced processing techniques: Reduce allergenicity and regulate digestion of beta-lactoglobulin

Structure-guided Engineering of Aptamers to Enhanced Structural Stability and Application Performance in Alleviating Β-Lactoglobulin Allergenicity

High-affinity Aptamer of Allergen Β-Lactoglobulin: Selection, Recognition Mechanism and Application

Effect of Fermentation in Combination with Protease Hydrolysis on the Antigenicity of Whey Protein

Determination of fbe mucosal immunoadjuvantivity of recombinant EschericMa cott LTKA63 mutant and LTB

Impacts of glycation and transglutaminase-catalyzed glycosylation with glucosamine on the conformational structure and allergenicity of bovine β-lactoglobulin.

Research on the Antigenicity of β-LG and α-LA in the Process of Skim Milk Fermentation

Characterization of the molecular properties and allergenicity (IgE-binding capacity) of β-lactoglobulin by heat treatment using asymmetric-flow field-flow fractionation and ultra-performance liquid chromatography quadrupole time of flight mass chromatography

Characterization of the immunomodulatory compound derived from beta‐lactoglobulin via Maillard reaction